Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 0 | 0 | 351,367 |
| Gross Profit | N/A | N/A | N/A | N/A | 351,367 |
| Operating Expenses | 180,887 | 192,950 | 164,162 | 130,650 | 212,990 |
| Operating Income | -180,887 | -192,950 | -164,162 | -130,650 | 138,377 |
| Other Income | 16,376 | 25,490 | 29,224 | 11,151 | 213 |
| Pre-tax Income | -164,511 | -167,460 | -134,938 | -119,499 | 138,590 |
| Income Tax | -6,162 | 925 | 1,018 | -3,590 | 17,400 |
| Net Income Continuous | -158,349 | -168,385 | -135,956 | -115,909 | 121,190 |
| Net Income | $-158,349 | $-168,385 | $-135,956 | $-115,909 | $121,190 |
| EPS Basic Total Ops | -1.94 | -2.00 | -1.63 | -1.39 | 1.46 |
| EPS Basic Continuous Ops | -1.94 | -2.00 | -1.63 | -1.39 | 1.46 |
| EPS Diluted Total Ops | -1.94 | -2.00 | -1.63 | -1.39 | 1.37 |
| EPS Diluted Continuous Ops | -1.94 | -2.00 | -1.63 | -1.39 | 1.37 |
| EPS Diluted Before Non-Recurring Items | -1.94 | -2.00 | -1.63 | -1.39 | 1.37 |
| EBITDA(a) | $-185,415 | $-204,355 | $-179,192 | $-135,855 | $138,406 |